BioCardia, Inc.BCDAEarnings & Financial Report
Nasdaq
NextMar 31, 2026
BCDA Q3 2025 Key Financial Metrics
Revenue
$0
Gross Profit
N/A
Operating Profit
$-1.5M
Net Profit
$-1.5M
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
YoY Growth
N/A
EPS
$-0.24
BioCardia, Inc. Q3 2025 Financial Summary
BioCardia, Inc. reported revenue of $0 for Q3 2025, with a net profit of $-1.5M (N/A margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $0 |
|---|---|
| Net Profit | $-1.5M |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Report Period | Q3 2025 |
BioCardia, Inc. Annual Revenue by Year
BioCardia, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $58.0K).
| Year | Annual Revenue |
|---|---|
| 2024 | $58.0K |
| 2023 | $477.0K |
| 2022 | $1.4M |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $13000 | $55000 | $3000 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | -87.7% | -14.1% | -93.0% | N/A | N/A | N/A | N/A | N/A |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $3.0M | $2.7M | $2.9M | $6.3M | $3.7M | $2.2M | $2.1M | $6.1M |
| Liabilities | $4.6M | $5.0M | $4.9M | $3.5M | $2.9M | $3.7M | $4.0M | $3.5M |
| Equity | $-1.6M | $-2.3M | $-2.0M | $2.8M | $837000 | $-1.5M | $-1.9M | $2.6M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-1.9M | $-1.5M | $-1.3M | $-2.6M | $-2.6M | $-1.6M | $-1.6M | $-1.7M |